Pacer Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-176,109
Closed -$17.5M 1303
2019
Q3
$17.5M Buy
176,109
+11,812
+7% +$1.12M 0.39% 47
2019
Q2
$15.2M Buy
164,297
+6,051
+4% +$575K 0.37% 47
2019
Q1
$14.9M Buy
158,246
+109,237
+223% +$9.55M 0.41% 47
2018
Q4
$3.14M Sell
49,009
-18,450
-27% -$1.36M 0.11% 37
2018
Q3
$6.04M Buy
67,459
+10,802
+19% +$955K 0.23% 71
2018
Q2
$4.5M Buy
56,657
+2,095
+4% +$174K 0.2% 74
2018
Q1
$4.87M Buy
54,562
+11,763
+27% +$1.13M 0.27% 55
2017
Q4
$4.47M Buy
42,799
+11,434
+36% +$1.29M 0.31% 48
2017
Q3
$4.57M Buy
31,365
+2,899
+10% +$395K 0.41% 33
2017
Q2
$3.7M Buy
28,466
+3,239
+13% +$397K 0.37% 37
2017
Q1
$3.14M Buy
25,227
+1,673
+7% +$200K 0.38% 35
2016
Q4
$2.73M Sell
23,554
-757
-3% -$84.3K 0.39% 36
2016
Q3
$2.54M Sell
24,311
-656
-3% -$71K 0.39% 38
2016
Q2
$2.46M Buy
24,967
+30
+0.1% +$3.1K 0.39% 42
2016
Q1
$2.5M Buy
24,937
+580
+2% +$59.7K 0.57% 38
2015
Q4
$2.92M Buy
+24,357
New +$2.82M 0.69% 29

Other funds holding CELG

Pacer Advisors's CELG Position: Q4 2019 in Review

Pacer Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 176,109 shares — an estimated $17.5M sold.

Pacer Advisors first reported a position in CELG in Q4 2015 and held it in 16 quarters. The position peaked at $17.5M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Pacer Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Pacer Advisors sold 176,109 Celgene Corp shares in Q4 2019, an estimated $17.5M.
  • Pacer Advisors first reported a position in Celgene Corp in Q4 2015 and held it in 16 quarters.
  • Pacer Advisors's Celgene Corp position peaked at $17.5M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Pacer Advisors's 13F filing for Q4 2019, filed 10 Feb 2020.